Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-03

Clinical Trial Update: Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneous kisspeptin in people with reproductive disorders; the study focusing on hypothalamic amenorrhea and hypogonadotropic hypog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kisspeptin (Kisspeptin)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism | Phase 1 | Status: COMPLETED